Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors

Purpose The PRESTIGIO Registry was established in 2017 to collect clinical, virological and immunological monitoring data from people living with HIV (PLWH) with documented four-class drug resistance (4DR). Key research purposes include the evaluation of residual susceptibility to specific antiretro...

Full description

Bibliographic Details
Main Authors: Roberta Gagliardini, Maria Mercedes Santoro, Filippo Lagi, Stefano Rusconi, Antonella Castagna, Emanuele Focà, Antonio Di Biagio, Micol Ferrara, Franco Maggiolo, Giulia Marchetti, Laura Galli, Vincenzo Spagnuolo, Riccardo Lolatto, Tommaso Clemente, Anna Maria Cattelan, Adriana Cervo, Leonardo Calza, Giovanni Cenderello, Maurizio Zazzi
Format: Article
Language:English
Published: BMJ Publishing Group 2024-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/2/e080606.full